Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'18
Mar'17
Mar'16
Mar'15
Mar'14
Mar'13
Mar'12
Net Sales
585.51
525.62
465.30
401.44
334.02
297.01
222.19
Other Operating Income
6.85
5.45
0.00
0.18
0.04
0.13
0.19
Total Operating income
592.37
531.07
465.30
401.62
334.06
297.13
222.37
Raw Material Cost
172.08
159.74
67.11
55.20
51.53
45.56
38.30
Purchase of Finished goods
0.00
0.00
76.81
66.60
54.75
47.29
36.04
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.63
-0.45
-1.11
-0.75
Employee Cost
98.22
87.73
79.36
64.60
52.69
48.69
32.51
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
192.97
158.62
70.42
119.95
102.25
85.74
72.09
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
0.00
-0.00
79.47
0.00
0.00
0.00
0.00
Total Expenditure (Excl Depreciation)
463.26
406.10
373.17
306.97
260.77
226.17
178.20
Operating Profit (PBDIT) excl Other Income
129.11
124.97
92.13
94.65
73.29
70.97
44.17
Other Income
7.52
6.04
7.61
6.60
4.51
2.84
1.26
Operating Profit (PBDIT)
136.63
131.01
99.74
101.25
77.81
73.81
45.44
Interest
12.86
14.72
16.66
20.38
23.94
27.46
16.58
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
123.77
116.29
83.08
80.87
53.86
46.34
28.86
Depreciation
34.33
23.87
20.74
21.61
16.48
15.83
12.61
Profit Before Tax
89.44
92.43
62.34
59.26
37.39
30.51
16.24
Tax
31.46
32.36
21.73
20.73
13.61
10.08
4.30
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
57.98
60.06
40.62
38.53
23.77
20.43
11.94
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
57.98
60.06
40.62
38.53
23.77
20.43
11.94
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
57.98
60.06
40.62
38.53
23.77
20.43
11.94
Equity Capital
10.94
10.94
10.94
10.94
10.94
10.94
10.94
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
163.08
125.76
90.25
68.40
49.89
Earnings per share (EPS)
52.99
54.89
37.12
35.22
21.73
18.67
10.91
Diluted Earnings per share
52.99
54.89
37.12
35.22
21.73
18.67
10.91
Operating Profit Margin (Excl OI)
21.79%
23.53%
19.8%
23.57%
21.94%
23.88%
19.86%
Gross Profit Margin
20.89%
21.9%
17.86%
20.14%
16.12%
15.6%
12.98%
PAT Margin
9.79%
11.31%
8.73%
9.59%
7.12%
6.88%
5.37%
Public Share Holdings (%)
0.0%
0.0%
0.0%
49.98%
50.16%
50.42%
51.27%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 12.43% vs 19.61% in Mar 2024
Standalone Net Profit
YoY Growth in year ended Mar 2025 is 16.26% vs 55.25% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 12.89% vs 27.25% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -0.79% vs -17.98% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Kovai Medical With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
585.51
880.49
-294.98
-33.50%
Other Operating Income
6.85
0.00
6.85
Total Operating income
592.37
880.49
-288.12
-32.72%
Raw Material Cost
172.08
178.53
-6.45
-3.61%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
98.22
162.50
-64.28
-39.56%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
192.97
0.00
192.97
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.00
319.27
-319.27
-100.00%
Total Expenditure (Excl Depreciation)
463.26
660.30
-197.04
-29.84%
Operating Profit (PBDIT) excl Other Income
129.11
220.19
-91.08
-41.36%
Other Income
7.52
16.18
-8.66
-53.52%
Operating Profit (PBDIT)
136.63
236.37
-99.74
-42.20%
Interest
12.86
7.51
5.35
71.24%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
123.77
228.86
-105.09
-45.92%
Depreciation
34.33
57.11
-22.78
-39.89%
Profit Before Tax
89.44
171.74
-82.30
-47.92%
Tax
31.46
41.19
-9.73
-23.62%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
57.98
130.55
-72.57
-55.59%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
57.98
130.55
-72.57
-55.59%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.01
0.01
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
57.98
130.55
-72.57
-55.59%
Equity Capital
10.94
96.35
-85.41
-88.65%
Face Value
10.00
10.00
0.00
Reserves
0.00
1,509.11
-1,509.11
-100.00%
Earnings per share (EPS)
52.99
13.55
39.44
291.07%
Diluted Earnings per share
52.99
14.72
38.27
259.99%
Operating Profit Margin (Excl OI)
21.79%
25.01%
0.00
-3.22%
Gross Profit Margin
20.89%
25.99%
0.00
-5.10%
PAT Margin
9.79%
14.83%
0.00
-5.04%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,369.74 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.43% vs 19.61% in Mar 2024
Annual - Standalone Net Profit
Standalone Net Profit 208.95 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 16.26% vs 55.25% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 385.72 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 12.89% vs 27.25% in Mar 2024
Annual - Interest
Interest 32.68 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.79% vs -17.98% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.16%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
